A recent study found that online cognitive behavioral therapy (CBT) intervention led to an improvement in sexual functioning for patients with breast cancer experiencing adverse effects.
Adverse effects associated with breast cancer treatment include impaired sexual functioning, negative body image, and emotional distress. Researchers in the Netherlands examined the effect of internet-based cognitive behavioral therapy (CBT) on sexual functioning and relationship intimacy (primary outcomes) and body image, menopausal symptoms, marital functioning, psychological distress, and health-related quality of life (secondary outcomes) in breast cancer survivors with a DSM-IV diagnosis of a sexual dysfunction.
Women were randomly assigned to an internet-based CBT program (84 women) or a waiting-list control group (85 women). The CBT consisted of weekly therapist-guided sessions, with a maximum duration of 24 weeks. Self-reported questionnaires were completed by the intervention group at baseline, mid-therapy, and post-therapy, and at the same times by the control group.
Compared with the control group, the intervention group showed a significant improvement over time in overall sexual functioning, which included an increase in sexual desire, sexual arousal, and vaginal lubrication. The intervention group reported more improvement over time in sexual pleasure, less discomfort, and less distress.
The intervention group also reported greater improvement in body image and fewer menopausal symptoms than the control group. No significant effects were observed for orgasmic function, sexual satisfaction, intercourse frequency, relationship intimacy, marital functioning, psychological distress, or health-related quality of life. The researchers concluded that internet-based CBT may improve sexual functioning and decrease distress experienced by breast cancer survivors. The study findings are available here.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.